Altium Capital

Altium Capital is a New York-based venture capital firm that focuses on investing in American small and microcap public companies in the healthcare industry.The partners at the company have backgrounds in the medical field, allowing them to understand the companies in which they invest. Specific medical products, services, and research in which it has invested include an oral injectable alternative for diabetes patients, the development of fatty acids, and the development of antibiotics.

The company has had one exit with Immutep, a start-up that develops immunotherapeutics in oncology.